Dermatology · Las Cruces, NM
NPI
1962429563
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
141 N Roadrunner Pkwy Ste 228
Las Cruces, NM, 88011
Phone (575) 521-1177
Groups this clinician bills Medicare through
Medicare paid, 2024
$702K
15,388 services
Medicare patients, 2024
2,717
Average age 75
Drug cost, 2024
$2.4M
8,290 prescriptions
Company payments, 2025
$572
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James D Kerner was code 17003 (destruction skin lesion), 3,868 times for 851 patients. In total James D Kerner billed 15,388 services in 97 codes, and Medicare paid $702K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,868 | 851 | $4.65 | $18K |
| 99213 Office E&M - Established | Office | 2,711 | 1,943 | $58.62 | $159K |
| 11102 Skin Biopsy | Office | 1,754 | 1,402 | $63.13 | $111K |
| 17000 Destruction Skin Lesion | Office | 1,398 | 1,064 | $32.90 | $46K |
| 88305 Surgical Pathology Examination | Office | 1,283 | 636 | $26.92 | $35K |
| 11103 Skin Biopsy | Office | 719 | 475 | $36.56 | $26K |
| 99214 Office E&M - Established | Office | 584 | 455 | $79.27 | $46K |
| 17110 Destruction Skin Lesion | Office | 428 | 375 | $74.63 | $32K |
| 99203 Office E&M - New | Office | 427 | 427 | $66.01 | $28K |
| 99212 Office E&M - Established | Office | 327 | 291 | $39.25 | $13K |
| 17281 Destruction Skin Lesion | Office | 198 | 173 | $118.06 | $23K |
| 17262 Destruction Skin Lesion | Office | 166 | 147 | $115.13 | $19K |
| 17261 Destruction Skin Lesion | Office | 131 | 121 | $81.17 | $11K |
| 99204 Office E&M - New | Office | 120 | 120 | $102.87 | $12K |
| 69100 Other Organ Systems | Office | 99 | 94 | $48.56 | $4,808 |
By year: 2022 $603K for 14,693 services; 2023 $637K for 14,766 services; 2024 $702K for 15,388 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,283 | 636 | $26.92 | $35K |
| 88304 Surgical Pathology Examination | 75 | 66 | $8.22 | $616 |
Medicare prescription drug claims, 2024
In 2024, the drug James D Kerner prescribed most often to Medicare patients was Imiquimod, with 1,072 prescriptions and refills. In total James D Kerner wrote 8,290 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imiquimod Generic | 1,072 | 1,125 | 853 | $13K |
| Mupirocin Generic | 759 | 759 | 634 | $6,990 |
| Minoxidil Generic | 699 | 1,458 | 199 | $5,726 |
| Dutasteride Generic | 687 | 1,326 | 182 | $17K |
| Ketoconazole Generic | 568 | 640 | 291 | $7,996 |
| Triamcinolone Acetonide Generic | 433 | 507 | 285 | $4,363 |
| Doxycycline Hyclate Generic | 307 | 413 | 98 | $8,675 |
| Mometasone Furoate Generic | 259 | 279 | 190 | $4,015 |
| Doxepin Hcl Generic | 233 | 255 | 127 | $8,357 |
| Fluocinonide Generic | 228 | 251 | 157 | $9,784 |
| Tacrolimus Generic | 212 | 227 | 119 | $21K |
| Cefdinir Generic | 211 | 211 | 187 | $1,027 |
| Ciclopirox Generic | 163 | 177 | 89 | $7,574 |
| Clobetasol Propionate Generic | 158 | 165 | 94 | $6,275 |
| Diclofenac Sodium Generic | 125 | 130 | 98 | $7,461 |
Brand drugs: - claims; generic drugs: 7,846 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James D Kerner $572 ($572 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $164.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 8 | $164 |
| Abbvie Inc. ABBV | 5 | $94.23 |
| Amgen Inc. AMGN | 6 | $94.12 |
| Genzyme Corporation SNY | 4 | $68.79 |
| Organon LLC OGN | 3 | $35.14 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.55 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $29.51 |
| UCB, Inc. UCB.BR | 1 | $18.57 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $16.48 |
| Smith+Nephew, Inc. SNN | 1 | $15.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.